Amgen (AMGN) EBT Margin (2016 - 2026)

Amgen has reported EBT Margin over the past 18 years, most recently at 24.18% for Q1 2026.

For Q1 2026, EBT Margin fell 3.0% year-over-year to 24.18%; the TTM value through Mar 2026 reached 24.41%, up 493.0%, while the annual FY2025 figure was 24.42%, 1063.0% up from the prior year.
EBT Margin for Q1 2026 was 24.18% at Amgen, up from 15.35% in the prior quarter.
Over five years, EBT Margin peaked at 380.83% in Q4 2022 and troughed at 0.91% in Q1 2024.
A 5-year average of 44.73% and a median of 24.18% in 2026 define the central range for EBT Margin.
Biggest five-year swings in EBT Margin: skyrocketed 34970bps in 2022 and later crashed -37043bps in 2023.
Year by year, EBT Margin stood at 380.83% in 2022, then plummeted by -97bps to 10.4% in 2023, then dropped by -17bps to 8.61% in 2024, then surged by 78bps to 15.35% in 2025, then soared by 58bps to 24.18% in 2026.
Business Quant data shows EBT Margin for AMGN at 24.18% in Q1 2026, 15.35% in Q4 2025, and 41.03% in Q3 2025.

Peer Comparison